Comparatively, in primary cancers, a high CYP24A1 expression has been associated with poor cancer cell differentiation in prostate cancer [28] and a poor clinical outcome in lung and colon cancers [30,50]. Here, CYP24A1 is linked to malignant colon neoplasm.